Agilent Technologies Inc (A) : Rs Investment Management Co reduced its stake in Agilent Technologies Inc by 19.2% during the most recent quarter end. The investment management company now holds a total of 2,149,542 shares of Agilent Technologies Inc which is valued at $101,587,355 after selling 510,784 shares in Agilent Technologies Inc , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Agilent Technologies Inc makes up approximately 0.99% of Rs Investment Management Co’s portfolio.
Other Hedge Funds, Including , Candriam Luxembourg S.c.a. reduced its stake in A by selling 67,579 shares or 27.55% in the most recent quarter. The Hedge Fund company now holds 177,760 shares of A which is valued at $8,400,938. Agilent Technologies Inc makes up approx 0.21% of Candriam Luxembourg S.c.a.’s portfolio.Robeco Institutional Asset Management B.v. boosted its stake in A in the latest quarter, The investment management firm added 146,710 additional shares and now holds a total of 202,094 shares of Agilent Technologies Inc which is valued at $9,413,539. Agilent Technologies Inc makes up approx 0.07% of Robeco Institutional Asset Management B.v.’s portfolio. Quantres Asset Management Ltd added A to its portfolio by purchasing 42,500 company shares during the most recent quarter which is valued at $1,979,650. Agilent Technologies Inc makes up approx 1.18% of Quantres Asset Management Ltd’s portfolio.Windward Capital Management Co Ca reduced its stake in A by selling 77 shares or 1.31% in the most recent quarter. The Hedge Fund company now holds 5,801 shares of A which is valued at $271,487. Agilent Technologies Inc makes up approx 0.05% of Windward Capital Management Co Ca’s portfolio.
Agilent Technologies Inc opened for trading at $47.49 and hit $48.175 on the upside on Friday, eventually ending the session at $48.11, with a gain of 1.26% or 0.6 points. The heightened volatility saw the trading volume jump to 18,81,372 shares. Company has a market cap of $15,661 M.
On the company’s financial health, Agilent Technologies Inc reported $0.44 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on May 16, 2016. Analyst had a consensus of $0.39. The company had revenue of $1019.00 million for the quarter, compared to analysts expectations of $983.35 million. The company’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.38 EPS.
Many Wall Street Analysts have commented on Agilent Technologies Inc. Company shares were Reiterated by Jefferies on May 17, 2016 to “Buy”, Firm has raised the Price Target to $ 51 from a previous price target of $46 .Company shares were Reiterated by Barclays on May 17, 2016 to “Equal Weight”, Firm has raised the Price Target to $ 45 from a previous price target of $42 .
Agilent Technologies Inc. is engaged in the life sciences diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments software services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business the diagnostics and genomics business and the Agilent CrossLab business. The Company’s life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment consists of three businesses: the Dako business the genomics business and the nucleic acid solutions business. The Company’s Agilent CrossLab business segment combines its analytical laboratory services and consumables business.